EyePoint Pharmaceuticals Q1 2025 Earnings Report

Expected Revenue:$8.09M
-18.9% YoY
Expected EPS:-$0.55
61.8% YoY

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals